Glaukos GKOS
NYSE GKOS
$187.28 -2.27 (-1.20%)
At close: Aug 20, 2026 · 1:26 PM UTC

Glaukos (GKOS) Gross Profit Growth (3y) (2017 - 2026)

Glaukos (GKOS) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 9.77%
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 12.24%
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 4.81%
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 14.82%
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 9.36%
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 14.95%
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 3.96%
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 3.99%
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 8.95%
10 Glaukos 11.03 Bn 10.92 Bn 151.59 Mn 35.98%

Historic Data

Download Data
DateValue
Jun 30, 2026 35.98%
Mar 31, 2026 28.06%
Dec 31, 2025 -26.58%
Sep 30, 2025 24.39%
Jun 30, 2025 21.02%
Mar 31, 2025 17.61%
Dec 31, 2024 10.89%
Sep 30, 2024 7.68%
Jun 30, 2024 6.63%
Mar 31, 2024 8.39%
Dec 31, 2023 5.77%
Sep 30, 2023 8.28%
Jun 30, 2023 82.68%
Mar 31, 2023 34.77%
Dec 31, 2022 2.64%
Sep 30, 2022 2.31%
Jun 30, 2022 2.64%
Mar 31, 2022 2.56%
Dec 31, 2021 6.28%
Sep 30, 2021 16.12%